Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, bottles of Duloxetine
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine (sold under the brand name Cymbalta) for potentially cancer-causing chemicals in the medication.
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
FDA issues recall for antidepressant drug
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous,
Duloxetine antidepressant recalled over presence of toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
FDA Recalls Thousands Of Duloxetine Antidepressant Bottles | Here's Why
The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high levels of a cancer-causing chemical. The federal agency has reportedly upgraded the level of risk.
1h
on MSN
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
13h
on MSN
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...
6m
FDA grants marketing authorisation to Peytant’s AMStent system
Peytant Solutions has received marketing authorisation from the US Food and Drug Administration (FDA) for its AMStent ...
14h
on MSN
Pfizer Receives FDA Approval for RSV Vaccine
Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...
Pharmaceutical Technology
1h
FDA approves Alvotech and Teva’s SELARSDI for new indications
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
STAT
11h
Novo asks FDA to bar compounders from making Ozempic copies
The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...
1d
US FDA declines to approve Camurus' rare hormone disorder drug
The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due ...
MassDevice
14h
iRhythm stock soars on FDA nod for changes to Zio AT following warning letter
Rhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance related to design changes made to its ...
STAT
17h
Michelle Tarver to lead FDA medical device center
Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
recall
United States
Pfizer
Duloxetine
Feedback